Medtronic Heart Valves Division recalls CoreValve Evolut PRO PLUS Delivery Catheter System, REF: D-EVPROP2329US; D-EVPROP34US;
- Recall date
- June 11, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2043-2021
- FDA classification
- Class II
- Brand / firm
- Medtronic Heart Valves Division
- Sold / distributed
- U.S.: AL, AK, AR, AZ, CA, CT, DE, DC, FL, GA, HI, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NE, NH, NJ, NM, NV, NY, NC, ND, OH, OK, OR, PA, Puerto Rico, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV. O.U.S.: Albania, Argentina, Australia, Austria, Belarus, Belgium, Brazil, BULGARIA, Cana…
Why it was recalled
Due to reports of actuator separation for various delivery catheter systems. Affected products were manufactured before July 11, 2020.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
CoreValve Evolut PRO PLUS Delivery Catheter System, REF: D-EVPROP2329US; D-EVPROP34US;
Get recall alerts
Free email alert whenever Medtronic Heart Valves Division has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Medtronic Heart Valves Division